Canada markets closed

Vanda Pharmaceuticals Inc. (VNDA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.6200+0.1400 (+3.12%)
At close: 04:00PM EDT
4.5199 -0.10 (-2.17%)
After hours: 05:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 265.82M
Enterprise Value -113.04M
Trailing P/E 115.50
Forward P/E 30.30
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.38
Price/Book (mrq)0.49
Enterprise Value/Revenue -0.59
Enterprise Value/EBITDA 10.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-28.15%
S&P500 52-Week Change 322.36%
52 Week High 37.0000
52 Week Low 33.3000
50-Day Moving Average 34.2800
200-Day Moving Average 34.4721

Share Statistics

Avg Vol (3 month) 32.33M
Avg Vol (10 day) 33.86M
Shares Outstanding 557.54M
Implied Shares Outstanding 657.54M
Float 852.05M
% Held by Insiders 15.21%
% Held by Institutions 190.97%
Shares Short (Apr 15, 2024) 42.07M
Short Ratio (Apr 15, 2024) 40.57
Short % of Float (Apr 15, 2024) 44.53%
Short % of Shares Outstanding (Apr 15, 2024) 43.60%
Shares Short (prior month Mar 15, 2024) 43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 1.30%
Operating Margin (ttm)-15.67%

Management Effectiveness

Return on Assets (ttm)-1.36%
Return on Equity (ttm)0.47%

Income Statement

Revenue (ttm)192.64M
Revenue Per Share (ttm)3.36
Quarterly Revenue Growth (yoy)-29.80%
Gross Profit (ttm)N/A
EBITDA -10.94M
Net Income Avi to Common (ttm)2.51M
Diluted EPS (ttm)0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)388.26M
Total Cash Per Share (mrq)6.75
Total Debt (mrq)9.4M
Total Debt/Equity (mrq)1.73%
Current Ratio (mrq)4.94
Book Value Per Share (mrq)9.47

Cash Flow Statement

Operating Cash Flow (ttm)12.8M
Levered Free Cash Flow (ttm)-88.78M